Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Infections × Clarithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 14 Lymphoma, B-Cell, Marginal Zone 4 Recurrence 2 Neoplasms, Plasma Cell 2 Lymphoma 2 Pseudomyxoma Peritonei 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Infections 1 Helicobacter Infections 1 Chemotherapy Effect 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Appendiceal Neoplasms 1

Interventions

telavancin 1 monalizumab 1 fludarabine phosphate 1 fish oil triglycerides 1 avdoralimab 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Therapeutics 1 Tacrolimus 1 Standard of Care 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Observation 1 Methotrexate 1 Melphalan 1 Interferon-gamma 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Cyclophosphamide 1 Clarithromycin 1 Caspofungin 1 Bevacizumab 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡